ABT-263, an Inhibitor of Bcl-2 Family Antiapoptotic Proteins, Sensitizes Prometaphase-Arrested HeLa Cells to Apoptosis Induced by Mild Hyperthermia

References (52)

1. 1 Caspases: Enemies Within [DOI]
2. 2 Maturation of the head of bacteriophage T4 [DOI]
3. 3 A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [DOI]
4. 4 ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets [DOI]
5. 5 Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis [DOI]
6. 6 The molecular machinery of regulated cell death [DOI]
7. 7 ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor [DOI]
8. 8 Induction of Apoptosis by Cancer Chemotherapy [DOI]
9. 9 Apoptotic Pathways [DOI]
10. 10 The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models [DOI]
11. 11 A chemical switch for inhibitor-sensitive alleles of any protein kinase [DOI]
12. 12 Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy [DOI]
13. 13 Apoptotic DNA Fragmentation [DOI]
14. 14 Apoptosis induced by anticancer drugs [DOI]
15. 15 The Bcl-2 Protein Family [DOI]
16. 16 Hyperthermia in oncology [DOI]
17. 17 Apoptosis-based therapies [DOI]
18. 18 Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32 [DOI]
19. 19 Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity [DOI]
20. 20 Bcl-2 inhibitors: small molecules with a big impact on cancer therapy [DOI]
21. 21 Phosphorylation of Mcl‐1 by CDK1–cyclin B1 initiates its Cdc20‐dependent destruction during mitotic arrest [DOI]
22. 22 Hyperthermia: an effective strategy to induce apoptosis in cancer cells [DOI]
23. 23 ABT-199, a new Bcl-2–specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia [DOI]
24. 24 The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells [DOI]
25. 25 Progress in targeting the BCL-2 family of proteins [DOI]
26. 26 ABT-199: Taking Dead Aim at BCL-2 [DOI]
27. 27 Selective targeting of antiapoptotic BCL‐2 proteins in cancer [DOI]
28. 28 Protein Complexes Activate Distinct Caspase Cascades in Death Receptor and Stress-Induced Apoptosis [DOI]
29. 29 The Role of Apoptosis in the Response of Cells and Tumours to Mild Hyperthermia [DOI]
30. 30 PROTEIN SYNTHESIS AND RNA SYNTHESIS DURING MITOSIS IN ANIMAL CELLS [DOI]
31. 31 In vivo localisation and stability of human Mcl‐1 using green fluorescent protein (GFP) fusion proteins [DOI]
32. 32 Functional analysis after rapid degradation of condensins and 3D-EM reveals chromatin volume is uncoupled from chromosome architecture in mitosis [DOI]
33. 33 Treating cancer with heat: hyperthermia as promising strategy to enhance apoptosis.
34. 34 Atypical APC/C‐dependent degradation of Mcl‐1 provides an apoptotic timer during mitotic arrest [DOI]
35. 35 The Biologic Rationale of Hyperthermia [DOI]
36. 36 S63845, an MCL-1 Selective BH3 Mimetic: Another Arrow in Our Quiver [DOI]
37. 37 Deoxyriboside Control and Synchronization of Mitosis [DOI]
38. 38 Evidence that the endogenous histone H1 phosphatase in HeLa mitotic chromosomes is protein phosphatase 1, not protein phosphatase 2A [DOI]
39. 39 Update: Turning the Heat on Cancer [DOI]
40. 40 Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells [DOI]
41. 41 Anticancer effects of β-elemene with hyperthermia in lung cancer cells [DOI]
42. 42 Repression of RNA Polymerase II and III Transcription during M Phase of the Cell Cycle [DOI]
43. 43 Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotheraphy [DOI]
44. 44 Isolation of chromosome clusters from metaphase-arrested HeLa cells [DOI]
45. 45 Therapeutic Applications of Apoptosis Research [DOI]
46. 46 Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia [DOI]
47. 47 Okadaic acid induces dephosphorylation of histone h1 in metaphase-arrested hela cells [DOI]
48. 48 On the structure of rhinovirus 1A [DOI]
49. 49 Moderate Hyperthermia Induces Apoptosis in Metaphase-Arrested Cells But Not in Interphase Hela Cells [DOI]
50. 50 Hyperthermia and its modern use in cancer treatment [DOI]
51. 51 The Coming Decade of Cell Death Research: Five Riddles [DOI]
52. 52 Death by design: mechanism and control of apoptosis [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Characterization of the Biochemical Pathway of Apoptosis Induced by D-glucopyranoside Derivatives from Tulbaghia violacea — shares topic coverage
• Pulmonary Arterial Hypertension and Cancer: An Update on Their Similarities — shares topic coverage
• Fetal Myocardial Reduction in Hyperglycemic Mouse Pregnancy is Associated with Dys-regulated Expression of the Anti-apoptotic Gene Bcl-2 in the Developing Heart. Preliminary Results — shares topic coverage
• Periodontitis: A Cellular Tactic to Escape Cancer — shares topic coverage
• Protective Effect of Artemisia judaica against Doxorubicin-Induced Toxicity in Mice — shares topic coverage